Keywords: gilead, adefovir, filed, hbv, sciences, first, phase

Gilead's adefovir to be filed for HBV in 2002

Article | 26 June 2001

Print This

Gilead Sciences' first Phase III study of adefovir dipivoxil in patientswith chronic hepatitis B virus infection has met its primary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in